Products for Research Use Only
RegisterLogin

RET-IN-29

CAT: 0931-T205680-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T205680-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
C-RET
Related Pathways
Tyrosine Kinase/Adaptors, Apoptosis
Bioactivity
RET-IN-29 (Compound 8W) is a selective RET kinase inhibitor. It demonstrates inhibitory effects on BaF3 cells with the CCDC6-RETV804M mutation, with an IC50 of 0.715 μM. RET-IN-29 shows potential for research in non-small cell lung cancer (NSCLC) .
Smiles
O=C(C=C1C)N(C2CCC2)C3=C1C=NC(NC4=NN(C5=C(C)C=CC=C5)C=C4)=N3
Molecular Formula
C22H22N6O
Molecular Weight
386.45
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T203439-01RET-IN-28
T201034-01RET-IN-27
T9673-01RET-IN-3
T63772-01RET-IN-5
T81296-01RET-IN-26
T79099-01RET-IN-23
T63782-01RET-IN-10
T63877-01RET-IN-17
T63468-01RET-IN-14
T79163-01RET-IN-24

Alternative Products

CatalogName
GTR19249099-01RET-IN-29
R1701-17RET protein (RET)
V8277-100UGRET Antibody / c-RET
V8276-100UGC-RET Antibody / RET
030598RET (ret proto-oncogene)
332425-01Ret

Popular Products